NextGen Sciences has sold its electrophoresis business to Sigma-Aldrich in exchange for a cash payment and royalty payments on revenues for three years. The deal involves the acquisition of the automated gel casting unit, the a2DEoptimizer and optigels, the range of large format pre-cast gels.
NextGen Sciences has sold its electrophoresis business to Sigma-Aldrich in exchange for a cash payment and royalty payments on revenues for three years. The deal involves the acquisition of the automated gel casting unit, the a2DEoptimizer and optigels, the range of large format pre-cast gels. Sigma-Aldrich will focus primarily on the supply of optigels, initially to the North American and European markets.
This announcement is the end of a strategic realignment of NextGen Sciences and follows on from the divestiture of the non-core ‘gene to protein’ automation and software business at the end of last year. Dr Michael Pisano, CEO of NextGen Sciences, commented: "The sale completes the disposal of our noncore businesses, enabling us to focus on our biomarkerexpress services. In future, customers for electrophoresis products will benefit from Sigma-Aldrich’s knowledge and reach."
Visit NextGen’s website at www.nextgensciences.com
For more about Sigma-Aldrich visit www.sigma-aldrich.com
Unlocking Metabolic Mysteries: Glioma Tumor Spheroids' Biochemical Blueprint Revealed
March 18th 2024In a recent study, researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College used liquid chromatography–mass spectrometry (LC–MS) to gain further insight into tumor metabolism.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.